Erratum to Survival difference between high-risk and low-risk CFTR genotypes after lung transplant. J Heart Lung Transpl 2022;41(10):1511-19. https://doi.org/10.1016/j.healun.2022.04.009

The publisher regrets that the author list was published incorrectly. Megan L. Neely has been added to the author list. The publisher would like to apologize for any inconvenience caused. Survival difference between high-risk and low-risk CFTR genotypes after lung transplantThe Journal of Heart and Lung TransplantationVol. 41Issue 10PreviewWhile cystic fibrosis transmembrane conductance regulator (CFTR) genotypes are associated with clinical outcomes in cystic fibrosis patients, it is unknown if genotype impacts lung transplant outcomes. We sought to compare lung transplant survival and time to bronchiolitis obliterans syndrome (BOS) between high-risk, low-risk, and not yet classified CFTR genotypes. Full-Text PDF